Henry Schein, Inc. (NASDAQ:HSIC) Stake Raised by Scientech Research LLC

Scientech Research LLC boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 271.6% during the 2nd quarter, Holdings Channel.com reports. The fund owned 30,307 shares of the company’s stock after purchasing an additional 22,152 shares during the quarter. Scientech Research LLC’s holdings in Henry Schein were worth $1,943,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Empirical Finance LLC raised its position in Henry Schein by 3.5% in the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after acquiring an additional 160 shares in the last quarter. Covestor Ltd raised its holdings in Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after buying an additional 171 shares during the period. Simplify Asset Management Inc. raised its holdings in Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after buying an additional 175 shares during the period. Sequoia Financial Advisors LLC raised its holdings in Henry Schein by 3.2% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after buying an additional 176 shares during the period. Finally, Wahed Invest LLC raised its holdings in Henry Schein by 9.2% during the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after buying an additional 187 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 1.5 %

Shares of Henry Schein stock opened at $70.86 on Friday. The stock has a market capitalization of $9.07 billion, a P/E ratio of 23.94, a PEG ratio of 2.01 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock has a 50 day moving average price of $70.04 and a two-hundred day moving average price of $70.26. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company’s revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 earnings per share. Equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent analyst reports. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Evercore ISI dropped their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. dropped their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $77.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.